Particle-specific neutralizing activity of a monoclonal antibody targeting the poxvirus A33 protein reveals differences between cell associated and extracellular enveloped virions-Reference-Cited by-同舟云学术

Particle-specific neutralizing activity of a monoclonal antibody targeting the poxvirus A33 protein reveals differences between cell associated and extracellular enveloped virions

Published:2020-05 Issue: Volume:544 Page:42-54
ISSN:0042-6822
Container-title:Virology
language:en
Short-container-title:Virology

Author:

Mucker Eric M.,Lindquist Michael,Hooper Jay W.

Funder

Defense Advanced Research Projects Agency

Publisher

Elsevier BV

Subject

Virology

Reference71 articles.

1. From the Centers for Disease Control and Prevention. Smallpox vaccine adverse events among civilians--United States, March 4-10, 2003;Anonymous;J. Am. Med. Assoc.,2003

2. An antigenic difference between intracellular and extracellular rabbitpox virus;Appleyard;J. Gen. Virol.,1971

3. Antibodies against the extracellular enveloped virus B5R protein are mainly responsible for the EEV neutralizing capacity of vaccinia immune globulin;Bell;Virology,2004

4. Vaccinia virus extracellular enveloped virion neutralization in vitro and protection in vivo depend on complement;Benhnia;J. Virol.,2009

5. Heavily isotype-dependent protective activities of human antibodies against vaccinia virus extracellular virion antigen B5;Benhnia;J. Virol.,2009

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of protection against mpox following mRNA or modified vaccinia Ankara vaccination in nonhuman primates;Cell;2024-09

2. Orally available nucleoside analog UMM-766 provides protection in a murine model of orthopox disease;Microbiology Spectrum;2024-04-02

3. Rapid development of double-hit mRNA antibody cocktail against orthopoxviruses;Signal Transduction and Targeted Therapy;2024-03-27

4. Functional epitopes and neutralizing antibodies of vaccinia virus;Frontiers in Microbiology;2023-10-25

5. An mpox virus mRNA-lipid nanoparticle vaccine confers protection against lethal orthopoxviral challenge;Science Translational Medicine;2023-10-04